![]() |
![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Product #: PTX-001 anti-GBMSheep Anti-Rat Glomeruli (GBM)
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Directions For Use:
1.
Preimmunization: To induce an accelerated passive anti-GBM nephritis
it is necessary to first immunize rats with sheep immunoglobulin(1). This
will allow the rats to produce antibodies to sheep IgG prior to administering
the anti-GBM antibody, thus accelerating the course of the disease. If
this step is omitted the rats will develop disease, however the response
will be weak and more protracted. A. Mixing the emulsion:
Each
rat will be injected with 0.5 ml of emulsion containing 5 mg sheep immunoglobulin
as immunogen. The emulsion is made with equal volumes of FCA and Sheep
immunoglobulin solution. For 25 rats we recommend making a total of 15
ml of emulsion 7.5 ml FCA plus 7.5 ml sheep immunoglobulin solution, because
the final mixture will be quite thick and recovery is not efficient. Mix
the immunoglobulin solution by inversion then withdraw 7.5 ml in 10 ml
syringe and put aside. Place a 20 ml syringe with the tip blocked to prevent
drainage (included in kit) upright in a bucket of ice. Place 7.5 ml of
FCA in the syringe. Firmly grip syringe and insert the homogenizer probe
into the syringe bore down into the FCA. Turn on the homogenizer to approximately
15,000 rpm moving the syringe up and down to completely mix the emulsion
from top to bottom of mixture. Slowly inject the immunoglobulin solution
into the FCA while continuing to mix the emulsion (this should take at
least 10 minutes, stop to cool the syringe and emulsion on ice intermittently
while mixing). Continue to mix another 5 minutes. The emulsion will be
ready when the syringe can be inverted at a 45 angle and the mixture is
too thick to run down the side. At this point remove the blockage at the
syringe tip and secure an 18-gauge needle. Put the needle in an inverted
glass syringe (not included) with plunger open to make space for the emulsion
to flow into. 5 ml glass syringes are recommended because 0.5 ml volumes
will be injected in rats and larger syringes generally do not have appropriate
graduations. Glass is recommended because the thick emulsion in a plastic
syringe with a rubber plunger becomes excessively difficult to push and
accurate injection volumes are not attainable. Place plastic plunger into
the 20 ml syringe and eject the emulsion into the open space in the glass
syringe to fill the glass syringe bottom up, without forming an air pocket.
When the glass syringe is filled, secure a 20 gauge needle and push the
plunger up until the air is fully expelled and the emulsion is at the
tip of the needle. The emulsion is now ready for injection. If fewer rats
are to be immunized, adjust the volumes proportionately. However the user
is advised that recovery of the emulsion is less efficient with smaller
volumes and the supplied reagents may be insufficient for a total of 25
rats. Excess sheep immunoglobulin and FCA have been provided to partially
compensate for this usage. B.
Immunization: This product has been determined to produce glomerulonephritis
in 175-200 gm male Sprague-Dawley rats. Anti-GBM disease can be elicited
in other rat strains, however, production of nephritis is genetically
predisposed and we cannot guarantee success with other strains or gender.
To immunize the rats, one person should hold the rat gently, but firmly
by placing a gloved hand over the shoulders of the animal with the head
toward the palm. Lift the skin on the nape of the neck, insert the needle
and inject no more than 0.1 ml of the emulsion. Repeat in additional subcutaneous
sites until a total of 0.5 ml has been injected. Multiple injections of
the emulsion are required to elicit a good immune response and to prevent
open abscesses. 2. Injection of anti-GBM: Five days after preimmunization with sheep immunoglobulin anesthetize rat(s). Inject 1.0 ml of anti-GBM antibody into a tail vein as a bolus over a 30 second period (Larger volumes are required for heavier rats). Allow the rat to recover and return to cage. Production of disease is dose dependent. For a more fulminant disease inject more volume of antibody. Doses over 2 ml are not recommended. It is important that the complete dose of antibody is delivered iv. If the investigator is not experienced with tail vein injections, we recommended a number of practice injections in sham rats before going forward antibody experiments.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Home | Products | Services | Resources | Protocols | About Us | FAQ | Links |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||